QUEEN'S BIOLOGY MCIB SEMINAR SERIES
  • Home
  • Schedule
  • Contact

Seminar series of the Molecular, Cellular & Integrative Biology
research groups at Queen's University

April 4, 2019 // Exploiting C. elegans as a Drug Development Platform

3/25/2019

 
Picture
Dr. Peter Roy, Dept Molecular Genetics, University of Toronto

The Roy Lab at the University of Toronto has spent over a decade exploring the utility of C. elegans in drug development.  In this seminar, Prof. Roy will introduce the nematode C. elegans as a tool for medium-throughput small-molecule screens.  He will then describe three vignettes that illustrate the power and peril of using C. elegans to develop small molecules that have utility beyond the bench.

March 21, 2019//  Career discovery: From a PhD to science communication and beyond

3/18/2019

 
Picture
Dr. Dawn Hall, Office of the Chief Information Officer, Treasury Board of Canada Secretariat, Government of Canada
​

When I obtained a PhD in Biology in 2007, I never would have predicted what the next 10+ years of my career would bring. This talk will begin with a retrospective look at my time as a PhD student and post-doc, followed by a description of the career experiences that have followed: from science communication and exhibit content development at the Ontario Science Centre, to exhibit interpretation for the renewal of the Canada Science and Technology Museum, to my current role as an analyst/advisor with the Government of Canada. Throughout, I will discuss the decisions that I made, and how the skills that were developed during my PhD and post-doc were applied in the jobs that have followed. I will also share lessons learned and perspectives from the career journey. 

March 7, 2019 // Drugs and environmental chemical-induced developmental toxicity

3/4/2019

 
Picture
Dr. Louise Winn, Dept of Biomedical and Molecular Sciences, Queen's University

​Drugs and environmental chemicals can harm the developing fetus by causing not only the commonly appreciated structural defects such as cleft lip, but also biochemical and functional abnormalities related to alterations in membranes as well as enzymes and other proteins. These compounds can also disrupt normal metabolic and endocrine signalling via epigenetic modifications, including DNA methylation, histone modifications, and/or RNA-mediated silencing of genes through miRNA, resulting in negative health outcomes later-in-life.My research program aims to investigate mechanisms of in utero initiated developmental toxicity employing a combination of expertise in biochemical and morphological assessment of chemical toxicity, and molecular toxicological approaches. Our goal is to answer fundamental mechanistic questions about the biological effects of in utero exposures to drugs and environmental chemicals to inform exposure monitoring practices, policy and human health assessments.

    Archives

    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    June 2020
    April 2020
    March 2020
    February 2020
    January 2020
    November 2019
    October 2019
    September 2019
    August 2019
    July 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    November 2018
    October 2018
    September 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    November 2017
    October 2017
    September 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016

Powered by Create your own unique website with customizable templates.
  • Home
  • Schedule
  • Contact